↓ Skip to main content

Cochrane Database of Systematic Reviews

Carbamazepine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
14 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
196 Mendeley
Title
Carbamazepine for schizophrenia
Published in
Cochrane database of systematic reviews, May 2014
DOI 10.1002/14651858.cd001258.pub3
Pubmed ID
Authors

Stefan Leucht, Bartosz Helfer, Markus Dold, Werner Kissling, John McGrath

Abstract

Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 <1%
Unknown 195 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 37 19%
Student > Bachelor 31 16%
Researcher 21 11%
Student > Ph. D. Student 19 10%
Student > Doctoral Student 17 9%
Other 39 20%
Unknown 32 16%
Readers by discipline Count As %
Medicine and Dentistry 69 35%
Psychology 29 15%
Nursing and Health Professions 21 11%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Agricultural and Biological Sciences 6 3%
Other 21 11%
Unknown 41 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2020.
All research outputs
#2,609,194
of 18,771,444 outputs
Outputs from Cochrane database of systematic reviews
#5,318
of 11,857 outputs
Outputs of similar age
#29,462
of 199,995 outputs
Outputs of similar age from Cochrane database of systematic reviews
#91
of 194 outputs
Altmetric has tracked 18,771,444 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,857 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,995 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 194 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.